Cardiovascular Disease, Valvular Disease, Chronic Kidney Disease research hub

Efficacy and safety of SP16 in preventing Acute Kidney Injury in at-risk subjects with chronic kidney disease undergoing elective cardiac surgery using the heart-lung-machine: A prospective, randomized, double-blind, placebo-controlled clinical trial (EASE-AKI)

This study looks at a new treatment, SP16, to see if it can protect kidneys in people with existing kidney problems who are having heart surgery. It aims to prevent a complication called Acute Kidney Injury (AKI) that can happen after surgery.